Comparison of three different definitions of low disease activity in patients with systemic lupus erythematosus and their prognostic utilities

被引:9
作者
Kang, Ji-Hyoun [1 ]
Shin, Min-Ho [2 ]
Choi, Sung-Eun [1 ]
Xu, Haimuzi [1 ]
Park, Dong-Jin [1 ]
Lee, Shin-Seok [1 ]
机构
[1] Chonnam Natl Univ, Med Sch & Hosp, Dept Internal Med, Div Rheumatol, 42 Jebong Ro, Gwangju 61469, South Korea
[2] Chonnam Natl Univ, Sch Med, Dept Prevent Med, Gwangju, South Korea
关键词
systemic lupus erythematosus; disease activity; damage; flare; quality of life; ACTIVITY STATE; INITIAL VALIDATION; DAMAGE; REMISSION; SLE; CLASSIFICATION; INDEX;
D O I
10.1093/rheumatology/keaa407
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Three definitions of low-level disease activity in patients with SLE have been proposed by different groups. These include minimal disease activity (MDA), low disease activity (LDA) and the lupus low disease activity state (LLDAS). We investigated the performance of these definitions in SLE patients. Methods We recruited 299 SLE patients who were followed up annually for 4 consecutive years. We compared the three definitions of low disease activity via longitudinal analysis; we used a generalized, linear-mixed effects model and generalized estimating equations. Results The LLDAS was significantly associated with a lower SLICC/ACR damage index (beta coefficient=-0.064, 95% CI: -0.129, -0.002, P=0.050), reduced flare (odds ratio = 0.090, 95% CI: 0.034, 0.239, P<0.001), an improved SF-36 physical component score (beta coefficient=0.782, 95% CI: 0.046, 1.519, P=0.037), and an improved SF-36 mental component score (beta coefficient=1.522, 95% CI: 0.496, 2.547, P=0.004). Neither the MDA nor the LDA were associated with these variables. Conclusion The LLDAS definition performs better than the MDA and LDA definitions, showing that LLDAS is associated with less organ damage and flare, and a better quality of life, during follow-up.
引用
收藏
页码:762 / 766
页数:5
相关论文
共 23 条
[1]   Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study [J].
Fanouriakis, Antonis ;
Adamichou, Christina ;
Koutsoviti, Sofia ;
Panopoulos, Stylianos ;
Staveri, Chrysanthi ;
Klagou, Anastasia ;
Tsalapaki, Christina ;
Pantazi, Lamprini ;
Konsta, Styliani ;
Mavragani, Clio P. ;
Dimopoulou, Despoina ;
Ntali, Styliani ;
Katsikas, Georgios ;
Boki, Kyriaki A. ;
Vassilopoulos, Dimitrios ;
Konstantopoulou, Pinelopi ;
Liossis, Stamatis-Nick ;
Elezoglou, Antonia ;
Tektonidou, Maria ;
Sidiropoulos, Prodromos ;
Erden, Abdulsamet ;
Sfikakis, Petros R. ;
Bertsias, George ;
Boumpas, Dimitrios T. .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2018, 48 (03) :467-474
[2]   Definition and initial validation of a Lupus Low Disease Activity State (LLDAS) [J].
Franklyn, Kate ;
Lau, Chak Sing ;
Navarra, Sandra V. ;
Louthrenoo, Worawit ;
Lateef, Aisha ;
Hamijoyo, Laniyati ;
Wahono, C. Singgih ;
Chen, Shun Le ;
Jin, Ou ;
Morton, Susan ;
Hoi, Alberta ;
Huq, Molla ;
Nikpour, Mandana ;
Morand, Eric F. .
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (09) :1615-1621
[3]   The development and initial validation of the systemic lupus international collaborating clinics American College of Rheumatology Damage Index for Systemic Lupus Erythematosus [J].
Gladman, D ;
Ginzler, E ;
Goldsmith, C ;
Fortin, P ;
Liang, M ;
Urowitz, M ;
Bacon, P ;
Bombardieri, S ;
Hanly, J ;
Hay, E ;
Isenberg, D ;
Jones, J ;
Kalunian, K ;
Maddison, P ;
Nived, O ;
Petri, M ;
Richter, M ;
SanchezGuerrero, J ;
Snaith, M ;
Sturfelt, G ;
Symmons, D ;
Zoma, A .
ARTHRITIS AND RHEUMATISM, 1996, 39 (03) :363-369
[4]   Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study [J].
Golder, Vera ;
Kandane-Rathnayake, Rangi ;
Huq, Moth ;
Nim, Hieu T. ;
Louthrenoo, Worawit ;
Luo, Shue Fen ;
Wu, Yeong-jian Jan ;
Lateef, Aisha ;
Sockalingam, Sargunan ;
Navarra, Sandra, V ;
Zamora, Leonid ;
Hamijoyo, Laniyati ;
Katsumata, Yasuhiro ;
Harigai, Masayoshi ;
Chan, Madelynn ;
O'Neill, Sean ;
Goldblatt, Fiona ;
Lau, Chak Sing ;
Li, Zhan Guo ;
Hoi, Alberta ;
Nikpour, Mandan ;
Morand, Eric F. .
LANCET RHEUMATOLOGY, 2019, 1 (02) :E95-E102
[5]   Development of the Korean version of short-form 36-item health survey: Health related QOL of healthy elderly people and elderly patients in Korea [J].
Han, CW ;
Lee, EJ ;
Iwaya, T ;
Kataoka, H ;
Kohzuki, M .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 203 (03) :189-194
[6]   Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [J].
Hochberg, MC .
ARTHRITIS AND RHEUMATISM, 1997, 40 (09) :1725-1725
[7]   Lupus disease activity and the risk of subsequent organ damage and mortality in a large lupus cohort [J].
Lopez, Rekha ;
Davidson, Julie E. ;
Beeby, Matthew D. ;
Egger, Peter J. ;
Isenberg, David A. .
RHEUMATOLOGY, 2012, 51 (03) :491-498
[8]   Classification and definition of major flares in SLE clinical trials [J].
Petri, M ;
Buyon, J ;
Kim, M .
LUPUS, 1999, 8 (08) :685-691
[9]   Comparison of Remission and Lupus Low Disease Activity State in Damage Prevention in a United States Systemic Lupus Erythematosus Cohort [J].
Petri, Michelle ;
Magder, Laurence S. .
ARTHRITIS & RHEUMATOLOGY, 2018, 70 (11) :1790-1795
[10]   Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus [J].
Piga, Matteo ;
Floris, Alberto ;
Cappellazzo, Giulia ;
Chessa, Elisabetta ;
Congia, Mattia ;
Mathieu, Alessandro ;
Cauli, Alberto .
ARTHRITIS RESEARCH & THERAPY, 2017, 19